Overview
Squamous Cell Lung Carcinoma (SCLC) is an aggressive form of lung cancer that begins in the flat cells that line the airways of the lungs. It is the second most common type of lung cancer and accounts for approximately 30 percent of all cases. SCLC is more common in men, smokers, and those over the age of 60. It is also linked to exposure to asbestos and other cancer-causing agents. Early diagnosis is key in treating SCLC and can improve the chances of successful treatment. Treatments used to fight SCLC include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapies. Without treatment, it can quickly spread to other parts of the body, including the brain, liver or bones.
Research published in this journal
No peer-reviewed research on this exact topic has been published in International Journal of Cell yet. Browse the journal →